Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page gains new user guidance sections for reading the study record and joining, and clearly signals recruitment has ended; formatting tweaks to the Intervention/Treatment header and a new version label (v3.6.0) are also present.
    Difference
    0.2%
    Check dated 2026-06-15T17:55:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.5, replacing the prior Revision: v3.5.4, indicating a small metadata update. There is no visible change to study content or user-facing features based on this update.
    Difference
    0.0%
    Check dated 2026-06-08T15:20:04.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing the previous revision v3.5.3 and signaling a new version of the page.
    Difference
    0.0%
    Check dated 2026-05-18T03:23:15.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website’s revision/build label for the ClinicalTrials.gov page was updated from v3.5.2 to v3.5.3, indicating a backend or UI version change rather than a change to the displayed study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:27:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:45:33.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added the Lancet Oncology publication citation for SERENA-2 and removed the associated Erratum reference.
    Difference
    0.0%
    Check dated 2026-04-05T06:18:14.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.